ARCH Global Precision has been sold to The Jordan Company
Lincoln acted as the exclusive investment banking representative for ARCH Global Precision, working closely with the company’s management team and shareholders throughout the sale process. This included providing advisory expertise and managing the preparatory, marketing, negotiation and due diligence phases of the transaction.
Eli Crotzer, ARCH’s CEO, commented, “Lincoln ran a highly competitive, disciplined process that, when combined with their extensive experience in the cutting tools and medical device sectors, resulted in a highly successful outcome for ARCH, its employees and its shareholders. With The Jordan Company, we have the ideal partner to support us in the next phase of continued strong growth.”
Headquartered in Bloomfield Hills, Michigan, ARCH is a leading metalworking platform focused on manufacturing precision cutting tools, precision machined industrial components and medical implants and instruments. ARCH’s management team has developed leading engineering, design and manufacturing expertise across the platform to produce complex solutions for industrial, medical and aerospace & defense applications. For more information, please visit www.archglobalprecision.com.
The Lincoln team did an excellent job understanding ARCH’s value proposition and effectively conveying the company’s organic growth and strategic acquisition strategy.
Meet our Senior Team
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical